b 107
Pill imprint b 107 has been identified as Metformin hydrochloride ER 750 mg.
Metformin is used in the treatment of diabetes, type 2; insulin resistance syndrome; female infertility; polycystic ovary syndrome and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy.
Metformin 750 mg is not subject to the Controlled Substances Act.
See also related documents.
Metformin hydrochloride ER Images
- Imprint:
-
b
107 - Strength:
- 750 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Non-sulfonylureas
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0107
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55887-0940 | Diversified Healthcare Services Inc (repackager) |
| 54868-5505 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More Metformin Hydrochloride ER resources
- Metformin
- Metformin (Wolters Kluwer)
- Metformin Extended-Release Tablets (Wolters Kluwer)
- Metformin Solution (Wolters Kluwer)
- metformin (Cerner Multum)
- metformin (Micromedex) - Includes Dosage Information
- Metformin Hydrochloride (AHFS DI)
- Metformin (FDA)
- Metformin Extended Release (FDA)
- Metformin Hydrochloride (Wolters Kluwer)


